Le Gall 1993 Simplified Acute Physiology Score II from 12 physiology variables (worst values in the first 24 hours as assigned by the caller), age, type of admission, and one chronic disease (AIDS, metastatic cancer, or hematologic malignancy). Max 163. Converts the integer to hospital-mortality probability with the paper's logit. PaO2/FiO2 is scored only if ventilated or CPAP. Not SAPS 3. Not APACHE. magent does not measure vitals.

SLICC 2012 SLE classification (Petri Table 3). classified iff biopsy-proven lupus nephritis plus ANA or anti-dsDNA, or at least four criteria including at least one clinical and one immunologic. 11 clinical and 6 immunologic caller flags. Direct Coombs counts only in the absence of hemolytic anemia. Criteria need not be concurrent. Not a diagnosis. Not 1997 ACR. Not 2019 EULAR/ACR. magent does not examine skin, assay serologies, or read a biopsy.

Yücel 2006 TASH (Trauma Associated Severe Hemorrhage): seven independent nested less-than point bands for arrival SBP, hemoglobin, intra-abdominal fluid, complex long-bone/pelvic fracture AIS, heart rate, base excess, and male sex; max 28. Highest matching band only (do not stack). Deterministic published arithmetic with citation; not a transfusion or MTP order; not ABC (assessment of blood consumption). Caller assigns FAST and AIS; magent does not read imaging.

ACR/EULAR 2015 gout classification (Neogi). MSU crystals classify without score ≥8; else score ≥8 (max 23). Pattern 0/1/2, characteristics 0–3, time course 0/1/2, tophus 4, urate −4 to 4, MSU-negative −2, imaging 4+4. Not a diagnosis. Not Janssens 2010. magent does not examine joints or polarizing microscopy.

Janssens 2010 diagnostic rule for acute gouty arthritis without joint fluid: male 2, previous arthritis attack 2, onset within 1 day 0.5, joint redness 1, MTP1 2.5, hypertension or CVD 1.5, uric acid >5.88 mg/dL or >350 µmol/L 3.5; max 13. Low ≤4, intermediate 4.5–7.5, high ≥8. uric_acid_mg_dl or uric_acid_umol_l, not both. Deterministic published score; not a gout diagnosis; magent does not examine joints or replace synovial crystal analysis.

Moreno 2005 SAPS 3 admission score from caller-assigned ICU-hour boxes (age, comorbidities, stay, location, vasoactive drugs, admission circumstances, and ten physiology items) plus the published 16-point offset. Converts the integer to hospital-mortality percent with the Part 2 global logit. Not SAPS II. Not APACHE. magent does not measure vitals.

Lee 2012 EHMRG 7-day ED model (Table 3 integer score): 2*age + 60 if EMS transport - min(SBP,160) + clamp(HR,80-120) - 2*min(SpO2,92) + 20*creatinine_mg_dl + K (<=3.9: +5; 4.0-4.5: 0; >=4.6: +30) + 60 if troponin>ULN + 45 if active cancer + 60 if home metolazone + 12. Groups 1/2/3/4/5a/5b. Dialysis-dependent excluded. Not EHMRG30-ST, not ADHERE CART, not a discharge or admission order.

Cacciola 2013 Brief Addiction Monitor (BAM; public-domain VA instrument). Three subscales only: Use (items 4+5+6, 0-90), Risk (items 1+2+3+8+11+15, 0-102 on Table 1 0-4 Likert plus 0-30 days), Protective (items 9+10+12+13+14+16, 0-98; income No=0 Yes=30). Items 7a-g and 17 collected, not summed. No total BAM score. magent does not interview the patient. Not a diagnosis, level-of-care order, or medical device.

Gladman 2002 SLEDAI-2K: weighted sum of 24 caller-assigned descriptors present in the last 10 days (max 105). magent does not examine the patient. Proteinuria scores if >0.5 g/24 h (not original SLEDAI >3.5 g/24 h only). Rash, alopecia, and mucosal ulcers score if new or persistent (not new only). Not a diagnosis, not SLICC damage, not SELENA-SLEDAI flare rules, and not a medical device.

Burch 1993 points: °F (<99→0, 99.0–99.9→5, 100.0–100.9→10, 101.0–101.9→15, 102.0–102.9→20, 103.0–103.9→25, ≥104→30); CNS 0/10/20/30; GI-hepatic 0/10/20; HR (<90→0, 90–109→5, 110–119→10, 120–129→15, 130–139→20, ≥140→25); HF 0/5/10/15; AF 10; precipitant 10. Max 140. <25 unlikely, 25–44 impending, ≥45 highly suggestive. temperature_f or temperature_c, not both. Not a diagnosis or ICU order. magent does not measure temperature or an ECG.

Misra 2013 ITAS2010: weighted sum of 44 caller-assigned Takayasu clinical-activity items that are new or worsening within 3 months and ascribed to active vasculitis. Seven items score 2 (diastolic hypertension, stroke, bruits, pulse inequality, pulse loss, claudication, carotidodynia); the other 37 score 1. Max 51. active_disease iff score ≥ 2. magent does not examine the patient. Not ITAS-A, not a diagnosis, and not a medical device.

Gélinas 2006 CPOT from four caller-assigned 0-2 items (facial_expression, body_movements, muscle_tension, plus ventilator_compliance when intubated or vocalization when extubated) using that paper's 0/1/2 descriptors. magent sums only (max 8) and does not observe the patient. No later intensity cutoffs. Not a pain diagnosis or analgesic order. Not PAINAD.

Berg 1992 Berg Balance Scale (BBS): fourteen caller-assigned integers 0-4 (sitting to standing through standing on one foot). Sum 0-56. magent does not observe. Berg 1992 printed no 0-20 wheelchair / 21-40 walking-with-assistance / 41-56 independent website bands. Not Timed Up and Go, not a diagnosis, and not a medical device.

Hanifin 2001 EASI from four regions. Each region: area 0-6 and erythema, edema/papulation, excoriation, and lichenification 0-3. Region score = (sum of signs) × area × adult weight (head/neck 0.1, upper extremities 0.2, trunk 0.3, lower extremities 0.4). Total max 72. Adult weights only. magent does not examine the skin. No IGA or later severity bands. Not a diagnosis.

Bush 1996 23-item catatonia rating scale from caller-assigned integers. Items 1-16 and 22-23 are 0-3; mitgehen, gegenhalten, ambitendency, grasp_reflex, and perseveration are 0 or 3 only. Severity is the sum of items 1-23 (max 69). The 14-item screen is positive iff at least two of items 1-14 score above 0. magent does not perform the standardized examination. Not a diagnosis, not DSM catatonia criteria, not a medical device.

Ntaios 2012 ASTRAL integer score for 3-month mRS >2 in acute ischemic stroke. Age 1/5 years + NIHSS (caller 0-42) + 2 if onset-to-admission >180 min + 2 if visual field defect + 1 if glucose <3.7 or >7.3 mmol/L (mg/dL /18) + 3 if impaired consciousness. Score 31 is 50% unfavorable. Not a tPA decision. magent does not compute NIHSS.

Maxwell 2008 Nottingham hip fracture score: age <=65 0, 66-85 3, >=86 4; male 1; hemoglobin <=10 g/dL 1 (g/L / 10); caller-assigned AMTS <=6, lives in institution, >=2 comorbidities, and malignancy 1 each. Max 10. Integer score only; no predicted 30-day mortality percent. magent does not administer AMTS or clear a patient for surgery. Not the 2012 or 2015 recalibrations.

Perry 2021 Canadian TIA Score (Table 1) for 7-day stroke or carotid revascularization after TIA. Clinical: first TIA 2, symptoms >=10 min 2, past carotid stenosis 2, antiplatelet 3, gait 1, unilateral weakness 1, vertigo -3, diastolic >=110 3, dysarthria/aphasia 1. Investigations: AF on ECG 2, infarct on CT 1, platelets >=400 2, glucose >=15 mmol/L 3. Age required, 0 points. Total -3 to 23. Bands <=3 low (0.5%), 4-8 medium (2.3%), >=9 high (5.9%). Not ABCD2. Not a diagnosis or admit order.

DRAGON (Strbian 2012 Neurology) for 3-month outcome after IV thrombolysis. CT hyperdense artery or early infarct 0/1/2, prestroke mRS >1 (1), age <65/65-79/>=80 (0/1/2), glucose >8 mmol/L (mg/dL /18) (1), onset-to-treatment >90 min (1), NIHSS 0-4/5-9/10-15/>15 (0/1/2/3); max 10. Tabulated mRS 0-2 and mRS 5-6 percents for scores 0-1, 2, 3, 8, and 9-10 only. Not a tPA decision. Not studied in basilar occlusion. magent does not read CT or assign NIHSS.

Greipp 2005 International Staging System for multiple myeloma. Stage I: serum beta-2 microglobulin <3.5 mg/L and albumin >=3.5 g/dL. Stage III: beta-2 microglobulin >=5.5 mg/L. Stage II: neither I nor III. Returns iss_stage 1/2/3. Not a myeloma diagnosis or treatment choice; not R-ISS (no LDH, no cytogenetics); not trauma ISS. magent does not assay beta-2 microglobulin or albumin.